当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 现金流量表

特一药业

(002728)

  

流通市值:33.05亿  总市值:45.01亿
流通股本:3.76亿   总股本:5.13亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金570,257,085.16334,097,865.17620,668,084.11462,720,929.03
  收到其他与经营活动有关的现金3,137,823.421,635,008.9611,969,937.968,265,675.56
  经营活动现金流入小计573,394,908.58335,732,874.13632,638,022.07470,986,604.59
  购买商品、接受劳务支付的现金135,528,055.0871,047,116.44313,341,321.1258,716,696.94
  支付给职工以及为职工支付的现金57,316,77929,021,318.36102,862,034.0178,455,268.98
  支付的各项税费49,723,211.0135,549,031.762,565,865.3247,863,980.13
  支付其他与经营活动有关的现金184,620,532.13110,731,651.83176,418,555.2124,225,606.96
  经营活动现金流出小计427,188,577.22246,349,118.33655,187,775.63509,261,553.01
  经营活动产生的现金流量净额146,206,331.3689,383,755.8-22,549,753.56-38,274,948.42
二、投资活动产生的现金流量:
  取得投资收益收到的现金299,726.03186,410.963,735,807.581,897,393.88
  处置固定资产、无形资产和其他长期资产收回的现金净额200,000200,00023,4802,940
  收到的其他与投资活动有关的现金110,000,00090,000,000892,010,000477,010,000
  投资活动现金流入小计110,499,726.0390,386,410.96895,769,287.58478,910,333.88
  购建固定资产、无形资产和其他长期资产支付的现金37,445,391.9919,330,790.44113,557,403.7276,640,328.26
  支付其他与投资活动有关的现金185,000,000140,000,000892,010,000692,010,000
  投资活动现金流出小计222,445,391.99159,330,790.441,005,567,403.72768,650,328.26
  投资活动产生的现金流量净额-111,945,665.96-68,944,379.48-109,798,116.14-289,739,994.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金11,086,308.4810,580,687.5213,877,365.5413,282,081.8
  取得借款收到的现金310,000,000160,000,0001,013,779,943.86820,000,000
  收到其他与筹资活动有关的现金154,000,000104,000,000530,000,000480,000,000
  筹资活动现金流入小计475,086,308.48274,580,687.521,557,657,309.41,313,282,081.8
  偿还债务支付的现金517,000,000417,000,000809,000,000486,000,000
  分配股利、利润或偿付利息支付的现金2,167,198.561,181,376.66182,307,116.95187,776,162.16
  支付其他与筹资活动有关的现金7,336,006.4791,594.14677,856,250.88577,856,250.88
  筹资活动现金流出小计526,503,205.03418,272,970.81,669,163,367.831,251,632,413.04
  筹资活动产生的现金流量净额-51,416,896.55-143,692,283.28-111,506,058.4361,649,668.76
五、现金及现金等价物净增加额-17,156,231.15-123,252,906.96-243,853,928.13-266,365,274.04
  加:期初现金及现金等价物余额302,961,723.49302,961,723.49546,815,651.62546,815,651.62
  期末现金及现金等价物余额285,805,492.34179,708,816.53302,961,723.49280,450,377.58
补充资料:
  净利润38,007,729.88-20,495,003.39-
  资产减值准备-2,302,376.77-12,235,985-
  固定资产和投资性房地产折旧28,268,607.64-51,755,137.99-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,268,607.64-51,755,137.99-
  无形资产摊销6,426,240.19-12,611,310.74-
  长期待摊费用摊销--52,500.17-
  处置固定资产、无形资产和其他长期资产的损失83,374.88--2,078.21-
  固定资产报废损失--163,055.68-
  财务费用3,073,825.93-5,299,835.17-
  投资损失-299,726.03--3,735,807.58-
  递延所得税2,993,489.38--902,419.59-
  其中:递延所得税资产减少3,139,353.84--4,837,757.58-
    递延所得税负债增加-145,864.46-3,935,337.99-
  存货的减少-21,827,924.9-6,702,686.39-
  经营性应收项目的减少66,936,115.77--42,918,019.35-
  经营性应付项目的增加24,846,975.39--85,028,867.56-
  其他--721,924.2-
  现金的期末余额285,805,492.34-302,961,723.49-
  减:现金的期初余额302,961,723.49-546,815,651.62-
  现金及现金等价物的净增加额-17,156,231.15--243,853,928.13-
公告日期2025-08-222025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑